Labiotech.eu

News and Trends 30 Dec 2015

3 EU Biotechs which Over-performed in 2015

2015 was a crazy year for the Biotech industry, probably the craziest since the birth of the industry 40 years ago. I looked back on this year and here’s my personal top 3 of EU Biotechs which over-performed. I sorted them out in top partnerships, clinical trials and fundraising. (Of course, this lists is not […]

December 30, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 29 Dec 2015

The 3 Worst Biotech Scandals of 2015!

2015 was tarnished by scandals that will certainly stay in minds for a long time (just need to mention the FIFA and Volkswagen to give you an idea). The Biotech world has not been spared by scandals and here is a quick overview of the worst of this year! I’m intentionally keeping it short but several […]

December 29, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 28 Dec 2015

The Review of Reviews – the Best Ones of 2015!

As you all are aware of this year, we have published a lot of brilliant reviews on some of the hottest topics in the Biotech Industry! This article highlights our favourite ones for 2015! Click the titles to read more… Review: The CRISPR’s Therapeutical revolution CRISPR has an enormous potential in therapeutic development and many […]

December 28, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 23 Dec 2015

7 Biotech-y Blockbusters to Chill Out With…

Tired of seeing a mini Macaulay Culkin in Home Alone – again – this Christmas? Don’t panic, here is a Biotech related film selection me and Nuria (our Events Manager) came up with for the sake for your survival’s sake this holiday… 1. Gattaca (1997) Directed by Andrew Nicole, with Ethan Hawke, Uma Thurman, Jude Law […]

December 23, 2015 - 6 minutesmins - By Dani Bancroft

crispr bayer therapeutics genetic disease joint venture london

News and Trends 22 Dec 2015

Serious Genetic Diseases have a New CRISPR Dream Duo Venture worth in Excess of €275M

Blood disorders, blindness and congenital heart disease? The new Bayer Life Science Center (BLSC) in Germany and CRISPR Therapeutics (Switzerland) have now created a joint Venture to tackle cures for these rare genetic defects. CRISPR Therapeutics will contribute its proprietary CRISPR-Cas9 gene-editing technology and intellectual property, while Bayer will make available its protein engineering expertise […]

December 22, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 22 Dec 2015

Dutch Organ-on-Chip Biotech Hauls in €1.5M Funding from Pharma Syndicate in Project Against Animal Testing

Mimetas from Leiden (NL) has now been financed to develop an Organ-on-Chip (tissue model) to specifically test Neurotoxicity, as a piece of medtech to help clinical trials move away from Animal testing… Organs-on-Chips are microfluidic tissue models which mimic basic organ-to-organ coupling. Developed with the aim of simulating ADMET testing and drug screening in vitro, […]

December 22, 2015 - 3 minutesmins - By Dani Bancroft

dompe generation biotech education italy aquila

News and Trends 21 Dec 2015

L’Aquila and Italian Education takes Flight with the New Project “GENEration Biotechnology”

The Italian Bio-pharma leader Dompé in the city L’Aquila has launched a new Educational resource program for schools and teachers to promote Biotechnology to the younger generation. Even though Italy has a large and international network of public and state universities and schools offering degrees in higher education, it is always a country associated with a lack […]

December 21, 2015 - 2 minutesmins - By Joachim Eeckhout

astrazeneca acerta pharma acquitision leukemia myeloma oncology cancer1

News and Trends 21 Dec 2015

Mystery Biotech No One has Ever Heard of in Biggest Deal of the Year for $7Bn

Acerta Pharma is an elusive Netherlands based Biotech with pipelines in Blood cancer and solid tumors which has somehow wrangled the biggest Biotech deal of 2015 with Pharma Giant AstraZeneca. Acerta Pharma is a Biotech start-up founded in 2012 which combines two technology platforms in drug discovery and development with a broad target range, from […]

December 21, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 21 Dec 2015

Here’s my Chat with the CBO of Immunocore, the Only EU Biotech to have ever raised €300M in one Round

Last Thursday at Genesis in London, I had the chance to meet with Eva-Lotta Allan, CBO of Immunocore (and previously from Ablynx). After a last-minute confirmation before the event, we came to meet and it helped me understand why Immunocore could be the next Biotech success-story in Europe… I’m sure you’ve heard of Immunocore this year. This […]

December 21, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 19 Dec 2015

What happened this week? Top 10 Biotech gifts, Documentary on India, 10 Medtech Inventions

Monday: Discover India’s Growing Biotech ecosystem in our Latest Documentary! Tuesday: Becoming Cyborg: 10 Amazing MedTech Inventions in the Biotech Industry Wednesday: Top 10 Biotech Gifts You NEED to Consider this Christmas! Thursday: The Assault on Solid Tumors: How ‘Blinding’ Cancer is an Attractive Therapeutic Approach Friday: Finally! Galapagos New Mystery Partner to Replace AbbVie […]

December 19, 2015 - 1 minutemin - By Philip Hemme

ablynx antibodies rsv infection nanobody llama

News and Trends 18 Dec 2015

64 Million RSV Infections Per Year: Perhaps Alpaca Nanobodies Will Save Infant Lives

Ablynx, the Alpaca Nanobody Biotech from Belgium, has completed target enrollment of the first-in-infant Phase I/IIa study with its anti-Respiratory Syncytial virus, which is linked to 3,000-8,500 infant deaths each year. ALX-0171 is a wholly-owned Nanobody drug candidate administered through inhalation (nebulisation), for the treatment of respiratory syncytial virus (RSV) infection in infants. The candidate […]

December 18, 2015 - 3 minutesmins - By Dani Bancroft

Gilead galapagos abbvie filgotinib partner rheumatoid

News and Trends 18 Dec 2015

Finally! Galapagos New Mystery Partner to Replace AbbVie Revealed in €2Bn Deal

At last! We now know the fate of Galapagos Phase III Rheumatoid Arthritis drug after AbbVie‘s shocking abandonment. The Mystery replacement partner has now been revealed as Gilead! Galapagos will receive an upfront payment of €670M from California’s Gilead, consisting of a license fee of €277M and a €393M equity investment in Galapagos. In addition, […]

December 18, 2015 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

3 EU Biotechs which Over-performed in 2015

The 3 Worst Biotech Scandals of 2015!

The Review of Reviews – the Best Ones of 2015!

7 Biotech-y Blockbusters to Chill Out With…

Serious Genetic Diseases have a New CRISPR Dream Duo Venture worth in Excess of €275M

Dutch Organ-on-Chip Biotech Hauls in €1.5M Funding from Pharma Syndicate in Project Against Animal Testing

L’Aquila and Italian Education takes Flight with the New Project “GENEration Biotechnology”

Mystery Biotech No One has Ever Heard of in Biggest Deal of the Year for $7Bn

Here’s my Chat with the CBO of Immunocore, the Only EU Biotech to have ever raised €300M in one Round

What happened this week? Top 10 Biotech gifts, Documentary on India, 10 Medtech Inventions

64 Million RSV Infections Per Year: Perhaps Alpaca Nanobodies Will Save Infant Lives

Finally! Galapagos New Mystery Partner to Replace AbbVie Revealed in €2Bn Deal

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!